Blair Lonsberry, OD: AbbVie/Allergan: Advisory Committee/Board Member (); Apellis: Speaker's Bureau (honoraria or other compensation) (); Sun Pharma: Speaker's Bureau (honoraria or other compensation) (); Tarsus: Advisory Committee/Board Member (); Thea Pharma: Advisory Committee/Board Member ()
This interactive course examines the use of oral pharmaceuticals in the treatment/management of a variety of conditions that the clinician will encounter in primary care optometry. Topical areas will range from managing conditions affecting the ocular and periocular tissues.
Learning Objectives:
Upon conclusion of this activity, attendees will be able to:
Identify and understand the diagnostic criteria for HSV keratitis and the appropriate oral and topical treatments
Identify and understand the diagnostic criteria for herpes zoster ophthalmicus and the appropriate oral and topical treatments
Identify and understand the diagnostic criteria for allergic and bacterial conjunctivitis and appropriate oral and topical treatments
Identify and understand the diagnostic criteria for blepharitis and meibomian gland dysfunction and appropriate oral and topical treatments
Identify and understand the diagnostic criteria for dry eye disease and importance of ruling out Sjogrens disease and appropriate oral and topical treatments
Identify and understand the diagnostic criteria for lid/periocular tissue disease (e.g. hordeola, preseptal cellulitis) and appropriate oral treatments
